Pharmaceutical packaging or entering the high period of mergers and acquisitions

In recent years, the pharmaceutical industry has fully recognized the importance of packaging design, coupled with the government's increasing investment in medical and health care, the future of China's pharmaceutical packaging market will usher in rapid growth. M&A and restructuring are one of the ways to benefit the development of the entire packaging machinery industry.

Packaging machinery has been developed in China for more than 30 years. Some large enterprises and big brands have been formed, but there are also many small enterprises that are not standardized. There are still many scattered resources that are not fully utilized. M&A and restructuring are one of the ways to benefit the development of the entire packaging machinery industry.

The total production value of China's pharmaceutical packaging industry has accounted for more than 10% of the total packaging industry in the country, which is much higher than the proportion of the entire pharmaceutical industry in the total industrial output value of the country. With the implementation of the new version of GMP, the industry has put forward new requirements for the hardware equipment of pharmaceutical companies, which has made the growth of a number of pharmaceutical equipment enterprises, and has also become an opportunity for the upgrading of the pharmaceutical packaging materials industry.

In recent years, the pharmaceutical industry has fully recognized the importance of packaging design, which plays an important role in helping patients comply with medication regulations, meet regulatory requirements, increase brand life and attractiveness, and therefore, pharmaceutical companies must conduct Innovation, the rate of response to the growing threat of counterfeit drugs, pharmaceutical companies will increasingly increase demand for the pharmaceutical packaging market. At the same time, with the continuous improvement of the living standards and health concepts of Chinese residents and the increasing investment of the government in the medical and health undertakings, China's pharmaceutical packaging market will usher in a relatively fast growth in the future.

At present, most of China's pharmaceutical packaging enterprises are small and medium-sized enterprises. With the acceleration of mergers and acquisitions in the pharmaceutical industry, higher demands will be placed on the production capacity and product quality of upstream pharmaceutical packaging enterprises. The changes in external market demand will prompt China. Pharmaceutical packaging is developing in the direction of scale, and mergers and acquisitions are undoubtedly one of the quicker ways to achieve scale.

Analysts pointed out that in the future, the merger and reorganization of China's pharmaceutical packaging industry will enter a high-profile stage. In January 2013, the Ministry of Industry and Information Technology, the Ministry of Finance, the National Development and Reform Commission and Other departments jointly issued the "Guiding Opinions on Accelerating the Merger and Reorganization of Key Industry Enterprises". The "Opinions" clarified the objectives and tasks of mergers and acquisitions of pharmaceutical industry enterprises: by 2015, the top 100 The sales revenue of domestic enterprises accounts for more than 50% of the whole industry, and the market share of the top 20 enterprises in the sales of major staple drugs reaches 80%, realizing the scale and intensification of basic drug production. Encourage upstream and downstream integration between R&D and production, APIs and preparations, Chinese herbal medicines and proprietary Chinese medicine companies, improve the industrial chain, and improve the efficiency of resource allocation.

2 Ply Toilet Paper

Toilet Paper Roll,Toilet Tissue Virgin Wood Pulp,Toilet Roll Paper,Toilet Tissue Paper Roll

Baoda Paper Enterprise Co., Ltd. , https://www.baodatissue.com